Capital Southwest (CSWC) Q2 2026 Earnings Call Transcript
Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
Overview
The company's earnings call summary and Q&A session highlight strong financial performance, strategic dividend changes, and a robust market strategy. Despite some slower growth in EBITDA and revenue, the company maintains a healthy outlook with diversified portfolios and conservative leverage. The transition to monthly dividends and potential legislative impacts are positive indicators. While there are concerns about healthcare investments and unclear guidance on some financial metrics, overall, the company's strategic initiatives and market activities suggest a positive outlook. Given the market cap, a 2% to 8% stock price increase is anticipated.
Key Financial Performance
Pretax Net Investment Income $0.61 per share, increased from the prior quarter. This increase was driven by a $1.3 million rise in fees and other income, offset by a $500,000 decrease in PIK income.
Undistributed Taxable Income (UTI) Balance $1.13 per share, up from $1 per share in the prior quarter. The growth was driven by $44.8 million in realized gains from equity exits over the last 12 months.
Realized Gains from Equity Exits $44.8 million over the last 12 months, contributing to the increase in UTI per share from $0.64 in September 2024 to $1.13.
Dividends Declared $0.64 per share for the December quarter, including $0.58 in regular dividends and a $0.06 supplemental dividend.
Capital Raised $350 million in aggregate principal of 5.95% notes due 2030. Proceeds were used to redeem $150 million notes due October 2026 and $71.9 million notes due August 2028 without a make-whole premium.
Equity Proceeds $40 million raised through the equity ATM program at a weighted average share price of $22.81 per share, or 137% of the prevailing NAV per share.
New Commitments $245 million in total new commitments to 7 new portfolio companies and 10 existing portfolio companies. 32% of the total capital commitments were follow-on financings.
On-Balance Sheet Credit Portfolio $1.7 billion, representing a 24% year-over-year growth from $1.4 billion as of September 2024.
Equity Co-Investment Portfolio 83 investments with a total fair value of $172 million, representing 9% of the total portfolio at fair value. Marked at 126% of cost, with $35.8 million in embedded unrealized appreciation.
Weighted Average Yield of Credit Portfolio 11.5%, with a weighted average leverage through security of 3.5x EBITDA.
Loans on Nonaccrual 1% of the investment portfolio at fair value.
Net Asset Value (NAV) Per Share $16.62 per share, up from $16.59 in the prior quarter. The increase was primarily driven by accretion from the ATM equity program.
Regulatory Leverage Debt-to-equity ratio of 0.91:1, up from 0.82:1 in the prior quarter. Pro forma regulatory leverage would be 0.82x after accounting for cash on hand.
You have reached the limit. Sign up to access full content
Get started
Operating Highlights
Deal flow in the lower middle market: $245 million in total new commitments to 7 new portfolio companies and 10 existing portfolio companies. Add-on financings accounted for 32% of total capital commitments this quarter.
New platform deals: Closed 17 new platforms with financial sponsors, including 85 unique private equity firms represented across the investment portfolio.
Capitalization: Raised $350 million in aggregate principal of 5.95% notes due 2030, used to redeem $150 million notes due October 2026 and $71.9 million notes due August 2028 without a make-whole premium.
Equity proceeds: Raised approximately $40 million in gross equity proceeds through the equity ATM program at a weighted average share price of $22.81 per share.
Portfolio growth: On-balance sheet credit portfolio grew to $1.7 billion, a 24% year-over-year increase from $1.4 billion in September 2024.
Portfolio diversification: 126 portfolio companies with 89.9% in first lien senior secured debt, 0.9% in second lien senior secured debt, and 9.1% in equity co-investments.
Dividend payments: Declared $0.58 in regular dividends and a $0.06 supplemental dividend for the December quarter, totaling $0.64 per share.
Balance sheet positioning: Maintained low leverage and significant liquidity with $719 million in cash and undrawn leverage commitments, ensuring flexibility in economic environments.
Conservative underwriting: New platform originations averaged senior leverage of 3.5x debt to EBITDA and 38% loan-to-value, reflecting a consistent conservative approach.
You have reached the limit. Sign up to access full content
Get started
Risk or Challenges
Market Conditions: The lower middle market remains highly competitive, leading to tight loan pricing for high-quality opportunities. This competitive environment could impact the company's ability to secure favorable terms for new investments.
Regulatory Leverage: The company's regulatory leverage increased to 0.91:1 from 0.82:1 in the prior quarter. While still within the target range, this increase could pose risks if macroeconomic conditions worsen or if the company faces unexpected financial pressures.
Economic Uncertainty: The company is maintaining a regulatory leverage cushion to mitigate capital markets volatility, indicating concerns about potential macroeconomic instability.
Portfolio Diversification: While the portfolio is broadly diversified, the company’s exposure to private equity-backed firms (93% of the credit portfolio) could pose risks if these firms face financial difficulties or market downturns.
Debt Maturities: Although the company successfully raised $350 million in new notes and redeemed older notes, the reliance on debt markets for liquidity could be a challenge if market conditions tighten.
Loan Nonaccruals: Loans on nonaccrual represent 1% of the investment portfolio at fair value. While this is a small percentage, any increase in nonaccrual loans could negatively impact financial performance.
Equity Co-Investments: The equity co-investment portfolio, while offering upside potential, represents 9% of the total portfolio. This exposure could lead to losses if the equity investments underperform.
You have reached the limit. Sign up to access full content
Get started
Guidance & Outlook
Revenue and Investment Income Projections: The company expects to continue generating consistent investment income, supported by a robust portfolio and disciplined underwriting. The weighted average yield of the credit portfolio is 11.5%, and the company anticipates maintaining this level of performance.
Dividend Guidance: The Board has declared a total of $0.64 per share in dividends for the December 2025 quarter, including $0.58 in regular dividends and a $0.06 supplemental dividend. The company expects to sustain supplemental dividends based on its current undistributed taxable income balance of $1.13 per share and unrealized appreciation in the equity portfolio.
Capital Structure and Liquidity Outlook: The company has strengthened its balance sheet by raising $350 million in 5.95% notes due 2030 and redeeming $221.9 million in notes due 2026 and 2028 without make-whole premiums. It plans to maintain a regulatory leverage ratio in the range of 0.8 to 0.95, with significant liquidity of $719 million to support future commitments and operations.
Portfolio Growth and Market Position: The company anticipates continued growth in its portfolio, which currently consists of 126 companies with a focus on first lien senior secured debt. It expects to leverage its relationships with private equity firms to source high-quality opportunities and maintain conservative underwriting standards.
Macroeconomic and Market Conditions: The company remains optimistic about its ability to navigate competitive market conditions in the lower middle market, supported by strong relationships with private equity firms and a diversified portfolio. It plans to remain active and opportunistic in all economic environments.
You have reached the limit. Sign up to access full content
Get started
Shareholder Return Plan
Regular Dividends: The Board of Directors declared a total of $0.58 in regular dividends for the quarter, payable monthly in October, November, and December 2025.
Supplemental Dividends: A quarterly supplemental dividend of $0.06 per share was declared, bringing total dividends for the December quarter to $0.64 per share.
Dividend Coverage: The company achieved 104% dividend coverage for the 12 months ended September 30, 2025, and 110% cumulative coverage since the launch of its credit strategy.
Undistributed Taxable Income (UTI): The UTI balance increased to $1.13 per share from $1 per share in the prior quarter, supporting the company's ability to distribute supplemental dividends.
You have reached the limit. Sign up to access full content
Get started
Key Q&A
Q:What does the pipeline look like heading into year-end, and how does it compare to previous quarters or a year ago?
A:The pipeline has seen a significant uptick in size, with $248 million in origination this past quarter, including 7 platform companies and 10 add-ons. The add-ons have been consistent, and the company expects 8 to 12 transactions per quarter. For the upcoming quarter ending 12/31, the volume is expected to be similar to the 9/30 quarter. The company has made significant progress with sponsor activity and expects growth to continue, with origination now closer to $150 million to $200 million per quarter compared to $100 million to $125 million previously.
Q:What are the CEO's top priorities for the firm heading into calendar 2026?
A:The CEO's priorities include monetizing the investment platform to enhance competitive positioning and bring in additional fees and economics. The company has grown its portfolio operations group internally over the last 8 months to improve scalability and is looking to add originators to the platform. The focus is on building for growth, increasing deal volume, and maintaining a larger funnel for better quality deals. The company is also focused on adding staff to prepare for future growth.
Q:What is the current credit quality and outlook for the portfolio companies?
A:The portfolio companies have shown about 10% annual growth in EBITDA and revenue over the last 12 months, which is healthy but slightly slower than the 15% growth seen 18-24 months ago. The companies are performing well, with no particular industry showing issues. The changing regulatory environment from the White House is being closely monitored. The portfolio is diversified by industry and company, with conservative loan-to-value ratios (36%) and leverage (3.4x). The company feels comfortable with its credit quality and outlook.
Q:What are the trends affecting companies performing below expectations in the portfolio?
A:Approximately 9% of the debt portfolio is performing below expectations. These companies are not in dire situations, as they have private equity sponsors supporting them. Issues are idiosyncratic rather than industry-wide. The company monitors underperforming assets by industry but does not see consistent correlations. The leverage levels for these companies are conservative, with defaults occurring between 4x and 6x leverage.
Q:What is the prepayment risk for the portfolio, and how does it impact yields?
A:About 20% of the portfolio is performing above expectations, but prepayment risk is mitigated by the portfolio's granularity. Prepayment rates are around 10% to 12% annually, despite 15% to 20% of the portfolio being in the top performance bucket. The company does not fear prepayments due to its diversified portfolio and ability to redeploy capital into debt yields. The weighted average yield fell by 30 basis points this quarter, primarily due to nonaccruals and spread compression.
Q:Are there any industries or segments the company is avoiding or being more discerning about?
A:The company is cautious about healthcare due to uncertainties around Medicare and Medicaid reimbursements. Government-funded companies are also challenging. The company partners with private equity groups with expertise in dynamic industries and structures deals with added spread, reduced leverage, and tighter terms to mitigate risks. The larger funnel allows the company to be more discerning in selecting investments.
Q:What is the company's strategy for adding new originators and staff?
A:The company is looking to add originators to cover underrepresented regions and bring in analysts to support the team. They are also hiring for operations roles to enhance decision-making and scalability. The strategy includes hiring both experienced professionals and new graduates to build a scalable infrastructure for future growth.
Q:What is the company's approach to capital structure and interest rate changes heading into 2026?
A:The company has a diverse capital structure, including unsecured bonds, SBIC funding, and secured credit facilities. It plans to continue using SBIC as a primary source of new capital and maintain flexibility under secured credit facilities. There are no major shifts expected in the mix of unsecured debt, secured debt, and SBIC funding. The company is well-positioned to handle interest rate changes.
Q:Has competition from banks and nonbanks changed recently?
A:There has been some firming up in the market, but it is too early to determine if this is a widespread trend. The company continues to see competition from both banks and nonbanks.
Q:What is the status of monetizing the investment platform via asset management?
A:The company has been seeking partners to grow and monetize its investment platform for the past three years. It has honed in on the right structure and potentially found a like-minded partner. While there is no announcement yet, the company is hopeful to make progress in the near future.
Q:Is there any change in the company's approach to equity co-investments?
A:The company is interested in increasing equity co-investments, particularly in non-sponsored deals that require smaller debt checks and larger equity checks. However, these deals often have complexities, and the company is considering adding resources to pursue them. The current equity allocation is around 9%, and the company aims to grow this over the next 24 to 36 months.
Q:What is the company's outlook on yield dilution and commitments growth?
A:The company does not expect significant yield dilution from spread compression in the near term. The deals in the pipeline have similar yield profiles to recent quarters. While base rate changes (e.g., SOFR) are out of the company's control, it has built a portfolio and income statement positioned to handle such changes.
Q:Review of Unclear Management Responses
A:Management avoided providing specific details on the potential monetization of the investment platform, stating only that they are hopeful to make an announcement in the future. Additionally, they did not provide clear guidance on stock-based compensation and salary expenses for the fourth quarter, citing variability based on performance and staffing initiatives.
You have reached the limit. Sign up to access full content
Get started
Earnings Word Cloud
The most frequently occurring keywords in this quarter's earning call
ATM equity
Baker
Chief Investment
Investment Officer
Officer Chief
Officer capital
PIK
Southwest quarter
UTI share
accretion ATM
average commitment
bond maturity
bond redemption
capital raise
capital strength
case capital
cash balance
cash hand
commitment financing
commitment spread
company debt
company pari
concern term
cost debt
cost note
coverage strength
debt loan
decrease
driver
end proceeds
environment specific
financing portfolio
leverage debt
month platform
note end
percentage
potential
proceeds note
share increase
sheet leverage
source origination
specific investment
sponsor
transaction
value portfolio
CSWC Transcript
Capital Southwest (CSWC) Q2 2026 Earnings Call Transcript
Positive11-4
The company's earnings call summary and Q&A session highlight strong financial performance, strategic dividend changes, and a robust market strategy. Despite some slower growth in EBITDA and revenue, the company maintains a healthy outlook with diversified portfolios and conservative leverage. The transition to monthly dividends and potential legislative impacts are positive indicators. While there are concerns about healthcare investments and unclear guidance on some financial metrics, overall, the company's strategic initiatives and market activities suggest a positive outlook. Given the market cap, a 2% to 8% stock price increase is anticipated.
Capital Southwest (CSWC) Q1 2026 Earnings Call Transcript
Unknown8-7
The earnings call summary reveals a complex picture. While there are positives like active deal pipelines and reduced operating leverage, concerns remain about competitive pressure leading to spread compression and vague management responses on key issues. The Q&A section highlighted uncertainties about the dividend policy and competitive landscape, leading to a cautious sentiment. Given the company's small market cap, these mixed signals could lead to a stock price movement within the neutral range (-2% to 2%) over the next two weeks.
Capital Southwest (CSWC) Q2 2025 Earnings Conference Call Transcript
Positive10-29
The earnings call summary indicates a stable financial performance with consistent dividends and a flexible share repurchase program. Despite a slight decline in investment income and NAV, the company maintains strong cash flow coverage and portfolio growth. The Q&A reveals optimism about significant net portfolio growth and available capital, although there are concerns about non-accruals and market activity. Overall, the positive elements, including dividend coverage and growth potential, outweigh the negatives, suggesting a positive stock price movement, especially for a small-cap company with a market cap of $1.19 billion.
Capital Southwest (CSWC) Q4 2024 Earnings Call Transcript
Positive5-15
The earnings call summary highlights strong financial performance with increased dividends and solid portfolio growth. Despite some refinancing risks and net realized losses, management has effective mitigation strategies. The Q&A session reveals manageable credit risks and a robust yield position. The company's strategic focus on conservative leverage and diversification through SPV facilities is positive. Analysts' concerns about non-accruals and downgrades are addressed, indicating stability. The market cap suggests moderate sensitivity to news. Overall, the positive elements outweigh the negative, leading to a positive stock price prediction.
CSWC Slides
CSWC Report
Frequently Asked Questions
Where does this earnings call transcript come from?
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
How soon is the transcript available after the earnings call ends?
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
Is the transcript edited or altered in any way?
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
Why do some answers appear as “Unclear” or “Inaudible”?
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
Who creates the AI Summary and Key Q&A highlights shown above the transcript?
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.
